Non-sedating antihistamines and cardiac arrhythmia
- 1 October 1997
- journal article
- Published by Elsevier in The Lancet
- Vol. 350 (9085) , 1115-1116
- https://doi.org/10.1016/s0140-6736(05)63783-x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Risks of non-sedating antihistaminesThe Lancet, 1997
- Use of Terfenadine and Contraindicated DrugsJAMA, 1996
- Cardiac Actions of AntihistaminesAnnual Review of Pharmacology and Toxicology, 1996
- Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: Distinguishing a drug effect from spontaneous variabilityAmerican Heart Journal, 1996
- Electrophysiologic Mechanisms of the Long QT Interval Syndromes and Torsade de PointesAnnals of Internal Medicine, 1995
- Cardiac Electrophysiological Actions of the Histamine H 1 -Receptor Antagonists Astemizole and Terfenadine Compared With Chlorpheniramine and PyrilamineCirculation Research, 1995
- Risk of developing life-threatening ventricular arrhythmia associated with terfenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastineThe American Journal of Cardiology, 1994
- Mechanism of the Cardiotoxic Actions of TerfenadineJAMA, 1993
- Terfenadine-Ketoconazole InteractionJAMA, 1993
- Torsades de Pointes Occurring in Association With Terfenadine UseJAMA, 1990